Press Releases

SAN FRANCISCO, Nov. 12, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today reported third quarter 2019 financial results for the period ending Septembe

HOLLISTON, Mass., Nov. 12, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing next-generation esophageal implants, today announced its financial results for th

DUBLIN, Nov. 12, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the receipt of a $150 million milestone payment from Biogen triggered by the recen

JERUSALEM, Nov. 12, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three and nine months ended September 30, 2019.Highlights of the third quarter 2019 and recent weeks include: Presented two posters highlighting data from the Com

NEW YORK, November 12, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced positive results from the initial cohort of the Phase IIb trial evaluating the efficacy and safety of its lead oral insulin candidate, ORMD-0801, which has th

MIAMI, Nov. 12, 2019 /PRNewswire/ -- ArisGlobal, the visionary technology provider of automated solutions for the life sciences industry, is proud to announce that ten life sciences companies have switched to its industry-leading LifeSphere® MultiVigilance

REHOVOT, Israel, Nov. 12, 2019 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today positive preliminary results from recently completed animal studies in its immuno-oncology program, wherein anti-tumor activity was tested

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurovalens, a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today launches its Modius SLEEP campaign on Indiegogo. The device follows the success of the Company's first headset,

INDIANAPOLIS, Nov. 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the 52-week results from the Phase 3b/4 SPIRIT-Head-to-Head (H2H) study of Taltz® (ixekizumab) versus Humira® (adalimumab) in biologic-naïve patients with active psoriatic arthritis (PsA). The results are bein

MEMPHIS, Tenn., Nov. 12, 2019 /PRNewswire/ -- West Cancer Center is committed to closing the gap in cancer care disparity in the Mid-South. Since 1979, West has spent over $82 Million on uninsured and underinsured patients in an area where Memphis was ranked #1 in breast care mortality disparity.  Shelby